Study Protocol
Phase II dose-response pilot study of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in subjects with anxiety associated with advanced-stage cancer.
Principal Investigator:	John H. Halpern, M.D.
Co-Investigators:	Todd D. Shuster, M.D. Arthur J. Siegel, M.D. Umadevi Naidoo, M.D.
IND:	#63,384-pending amendment, October 15, 2004
Sponsor:	Multidisciplinary Association for Psychedelic Studies